Knight Therapeutics | GUD - Capital Ordinário

Preço das Ações
6.14
Mudança Diária
0.04 0.66%
Mensal
-4.06%
Anual
-0.49%
Q1 Previsão
5.95




Capital Ordinário Alterar Data
Acasti Pharma USD 1000 261.04M 2024-12
Akebia Therapeutics USD 2K 0 2025-03
Alaunos Therapeutics USD 2.21M 2.2M 2025-09
Aurora Cannabis CAD 6.98B 907K 2024-12
Canopy Growth CAD 332.38M 127.23M 2025-09
Cronos Group USD 382.89M 286.14M 2025-09
Dianthus Therapeutics USD 42.85M 42.82M 2025-09
Ionis Pharmaceuticals USD 161.97M 836K 2025-12
IQVIA Holdings USD 169.6M 700K 2025-12
Knight Therapeutics CAD 99.68M 24.66K 2025-09
Moderna USD 391M 2M 2025-09
Omeros USD 611K 17K 2023-12
Organigram Holdings CAD 134.46M 438.86K 2025-09
Organon & Co USD 259.98M 18K 2025-09
Revvity USD 113.38M 2.7M 2025-12
Tectonic Therapeutic USD 14.86M 111.83K 2024-12
Tilray USD 1.06B 86.93M 2025-03
Viatris USD 1.16B 6.55M 2025-09
Xeris Pharmaceuticals USD 165.53M 165.51M 2025-09